- Company Information
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Updated:6/3/26
- Country/Territory:U.S.
- Headquarters:San Rafael, Calif.
- Industry:Pharmaceuticals
- CEO:Alexander Hardy
- Website:https://biomarin.com/
- Ticker:BMRN
- Company type:Public
- Revenues ($M):$3,221
- Profits ($M):$349
- Market value ($M):$10,864
- Number of employees:3,221
Market value as of March 31, 2026.
- $ millions% change
- Revenues ($M):$3,221.312.9%
- Profits ($M):$348.9-18.3%
- Assets ($M):$7,594-
- Total Stockholder Equity ($M):$6,087-
- Profit as % of Revenues:10.8%
- Profits as % of Assets:4.6%
- Profits as % of Stockholder Equity:5.7%
- Earnings Per Share ($):1.80
- EPS % Change (from prior fiscal year):-18.6%
- EPS % Change (5 year annual rate):-16.9%
- EPS % Change (10 year annual rate):-
- Total Return to Investors (last year):-9.6%
- Total Return to Investors (5 year, annualized):-7.5%
- Total Return to Investors (10 year, annualized):-5.5%
BioMarin Pharmaceutical stock chart
BioMarin Pharmaceutical in Fortune Rankings